Charles Schwab Investment Management Inc. Sells 46,847 Shares of Blend Labs, Inc. $BLND

Charles Schwab Investment Management Inc. decreased its position in shares of Blend Labs, Inc. (NYSE:BLND) by 2.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,794,329 shares of the company’s stock after selling 46,847 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.69% of Blend Labs worth $6,011,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Blend Labs by 4.6% during the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock worth $58,915,000 after acquiring an additional 775,091 shares during the period. Mackenzie Financial Corp increased its stake in Blend Labs by 18.4% in the first quarter. Mackenzie Financial Corp now owns 41,511 shares of the company’s stock valued at $139,000 after acquiring an additional 6,444 shares during the last quarter. Royce & Associates LP lifted its stake in Blend Labs by 18.8% in the first quarter. Royce & Associates LP now owns 961,251 shares of the company’s stock worth $3,220,000 after purchasing an additional 152,251 shares during the last quarter. Quadrant Private Wealth Management LLC lifted its stake in Blend Labs by 7.8% in the first quarter. Quadrant Private Wealth Management LLC now owns 81,801 shares of the company’s stock worth $274,000 after purchasing an additional 5,892 shares during the last quarter. Finally, Allianz Asset Management GmbH lifted its stake in Blend Labs by 1,002.6% in the first quarter. Allianz Asset Management GmbH now owns 117,375 shares of the company’s stock worth $393,000 after purchasing an additional 106,730 shares during the last quarter. Institutional investors own 52.56% of the company’s stock.

Blend Labs Stock Performance

Shares of Blend Labs stock opened at $3.61 on Thursday. The company has a market capitalization of $936.07 million, a P/E ratio of -24.03 and a beta of 1.24. The company has a fifty day moving average of $3.37 and a 200 day moving average of $3.43. Blend Labs, Inc. has a fifty-two week low of $2.63 and a fifty-two week high of $5.53.

Blend Labs (NYSE:BLND) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.05). The business had revenue of $31.52 million for the quarter, compared to the consensus estimate of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. Analysts forecast that Blend Labs, Inc. will post -0.19 EPS for the current year.

Insiders Place Their Bets

In other Blend Labs news, insider Nima Ghamsari sold 311,886 shares of Blend Labs stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $2.90, for a total value of $904,469.40. Following the sale, the insider directly owned 5,754,051 shares in the company, valued at approximately $16,686,747.90. The trade was a 5.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $2.87, for a total transaction of $71,750.00. Following the transaction, the insider owned 696,598 shares of the company’s stock, valued at $1,999,236.26. This trade represents a 3.46% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 561,736 shares of company stock worth $1,739,383. 35.52% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

BLND has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods cut their price target on shares of Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a report on Friday, August 8th. Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a report on Sunday, August 17th. Canaccord Genuity Group restated a “buy” rating and set a $5.25 target price on shares of Blend Labs in a report on Friday, August 22nd. JMP Securities restated a “market outperform” rating and set a $7.00 price target on shares of Blend Labs in a report on Wednesday, May 28th. Finally, UBS Group dropped their price objective on Blend Labs from $4.00 to $3.50 and set a “neutral” rating on the stock in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Blend Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $4.88.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.